Final Written Decision | Jul 28, 2017 | PAPER | BOARD |
EXPUNGED | Jun 20, 2017 | PAPER | BOARD |
Record of Oral Hearing | Jun 20, 2017 | PAPER | BOARD |
Notice of Filing Petitioners Demonstrative Exhibits | Apr 3, 2017 | PAPER | PETITIONER |
Petitioners Demonstrative Exhibits for Oral Argument | Apr 3, 2017 | PAPER | PETITIONER |
Notice of Filing of Patent Owner's Demonstrative Exhibits - IPR2016-00558 | Apr 3, 2017 | PAPER | PATENT OWNER |
Patent Owners Oral Argument Presentation - IPR2016-00558 | Apr 3, 2017 | PAPER | PATENT OWNER |
Patent Owners Objections to Petitioners Demonstrative Exhibits | Apr 3, 2017 | PAPER | PATENT OWNER |
ORDER Granting Request for Oral Argument | Mar 21, 2017 | PAPER | BOARD |
Patent Owner Reply to Petitioner Motion to Exclude | Mar 10, 2017 | PAPER | PATENT OWNER |
Petitioner's Opposition to Patent Owner's Motion to Exclude | Mar 6, 2017 | PAPER | PETITIONER |
PATENT OWNER¿¿¿S MOTION TO EXCLUDE | Feb 23, 2017 | PAPER | PATENT OWNER |
Patent Owner's Request for Oral Argument | Feb 23, 2017 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Hearing | Feb 9, 2017 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List of January 30, 2017 | Jan 30, 2017 | PAPER | PETITIONER |
EX 1096 Reply Declaration of Jed Fisher Ph.D. | Jan 30, 2017 | EXHIBIT | PETITIONER |
Petitioner's Reply to Patent Owner's Response | Jan 30, 2017 | PAPER | PETITIONER |
EX 1095 Hales Transcript of Cross Examination | Jan 30, 2017 | EXHIBIT | PETITIONER |
PATENT OWNER¿¿¿S OBJECTIONS TO EVIDENCE | Jan 23, 2017 | PAPER | PATENT OWNER |
Ex 1083 Singh | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1086 21 CFR 314 108 Oct 16 2016 | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1088 FDA Admin Docs NDA 21548 | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1089 Orange Book excerpts | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1084 Sinko ed Martins ch 23 | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1085 Amidon | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1087 21 CFR 316 3 | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1090 21 CFR 314 108 Oct 3 1994 | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1092 Ogden Transcript | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1091 Amprenavir structure | Jan 17, 2017 | EXHIBIT | PETITIONER |
Lupin Updated Exhibit List | Jan 17, 2017 | PAPER | PETITIONER |
EX 1093 FDA Admin Docs NDA 21548 Ogden Dep Exh | Jan 17, 2017 | EXHIBIT | PETITIONER |
EX 1094 Torres | Jan 17, 2017 | EXHIBIT | PETITIONER |
Notice of Filing Lupin Exhibits | Jan 17, 2017 | PAPER | PETITIONER |
EX 1082 Sinko Transcript | Jan 13, 2017 | EXHIBIT | PETITIONER |
Decision Granting Patent Owner's Motion for Pro Hac Vice Admission | Jan 3, 2017 | PAPER | BOARD |
Patent Owner's Notice of Appearance of Additional Backup Counsel re: Scott McMurry | Jan 3, 2017 | PAPER | PATENT OWNER |
Petitioners Notice of Cross Examination Deposition of Patent Owners Declarant Dewey Hales | Dec 27, 2016 | PAPER | PETITIONER |
NOTICE of Stipulation to Change Due Dates 2 and 4 | Dec 13, 2016 | PAPER | PETITIONER |
Petitioners Notice of Deposition of Patent Owners Declarant Richard Ogden PhD | Nov 30, 2016 | PAPER | PETITIONER |
Petitioners Notice of Deposition of Patent Owners Declarant Patrick Sinko PhD | Nov 30, 2016 | PAPER | PETITIONER |
Patent Owner Response to Second Lupin IPR | Oct 31, 2016 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Oct 31, 2016 | PAPER | PATENT OWNER |
VRTX Ex. 2017 R. Ogden Declaration in Support of Response to Institution | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2018 List of Documents Reviewed by Dr Ogden | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2019 Richard Ogden CV 10.16 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2020 Young et al., Resistance to HIV-1 Protease Inhibitors | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2021 Erickson, J.W. Chapter 1 HIV-1 Protease as a Target - 2001 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2022 Tomasselli, et al Targeting the HIV-protease..2000 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2023 Tomasselli, et al., Adv. In Antiviral. (1996) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2024 Saquinavir-Invirase Label (Feb. 27, 1997) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2025 (Saquinavir-Fortovase Label 2002.07.02) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2026 Ritonovir-Norvir Label (Aug. 2001) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2033 Jose Gatell, From amprenavir to GW433908, 2001 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2035 Moyle et al.,Principles and Practice of HIV-Protease...2001 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2036 Moyle, Overcoming Obstacles...2002 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2038 Safadi, et al., Pharmaceutical Research..1993 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2027 (Indinavir - Crixivan Label 2002.01.25) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2028 (Nelfinavir-Viracept Revised Label 1999.05.25) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2029 (Lexiva Approval Label 2003.10.20) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2030 A. Spaltenstein, et al., Highly Polar, Water-Soluble.. 2000 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2031 A. Corbett and A. Kashuba.....Mar 2002 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2032 C. Baker et al., Discovery of VX-175GW433908 1999 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2034 Lima et al, The Combined Effect of Modern..2009 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2037 Chesney et al., Adherence to HIV... vol 50, 11, June 2000, | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2039 Agenerase Label -(Agenerase Approval Label (1999.04.15) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2040 Hoy, et al., Australasian Society..........8184 (1996) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2042 -P.O. Gunnarson et al., Impairment..... 1990 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2043 Tugrul Kararli, Comparison of....1995 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2044 M. Nahar and N. K. Jain, Formulation and Evaluation.. 2005 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2046 Partaledis, et al., In vitro selection....1995 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2047 Nadler Interview - Fosamprenavir A New PI Option IAPAC Mon... | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2050 Wensing - Fifteen years of HIV...Antiviral Res 2010 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2051 Arvieux, et al., Amprenavir or Fosamprenavir.. (2005) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2053 Antonio Mastrolorenzo et al., Inhibitors..2007 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2041 P. Vierling and J. Greiner, Prodrugs of HIV..2003 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2045 Tisdale, et al., Cross-Resistance Analysis of Human... | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2048 Nadler, New Anti-HIV Protease Inhibitors Provide More..2003 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2049 Boyle, The Continuing Evolution of HIV Therapy.. 2003 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2052 Fleisher et al., Oral Absorption of 21-...(J. Pharm Sci 1986) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2055 De Jong, RS, Randomized comparison of etoposide..1997 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2056 Ross, L., et al., Fosamprenavir Clinical.. 2006 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2057 Chapman, T.M., et al., Fosamprenavir, Drugs 64....(2004) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2058 Lexiva Label (2005) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2062-Materials reviewed by Patrick Sinko, Ph.D. | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2063 Sinko's CV 08SEP16 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2054 Vertex Quarterly Progress Report Dec. 31, 1997 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2059 Ullrich, R. et al., ., Effects of Zidovudine.... (1992) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2060 Asmuth, D.M, et al., Physiological effects of HIV- 1994 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2061 P. Sinko Declaration in Support of Opposition to IPR | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2064 Lipkin, Martin,. Proliferation and Differentiation of.. 1987 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2065 Kearney et al., Pharmaceutical Research, 9(4) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2066 N. Ruiz-Balaguer et al., Nonlinear Intestinal ...1997 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2071 Declaration of Dewey Hales | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2069 (Agenerase Approval Letter 4.15.1999) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2068 (Lexiva Approval Letter 10.20.2003) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2070 S. Vella and M. Floridia, Saquinavir, Clin Pharmacokin.. 1998 | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2072- Collins, S. - HIV i-Base (Abbott Raises).. | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2067 Nelfinavir, O¿¿¿Neil et al., 13th Ed. (2001) | Oct 31, 2016 | EXHIBIT | PATENT OWNER |
PATENT OWNER¿¿¿S OBJECTIONS TO EVIDENCE | Oct 27, 2016 | PAPER | PATENT OWNER |
VRTX Exhibit 2016 Deposition Transcript of Jeb Fisher-IPR2016-00558 | Oct 27, 2016 | EXHIBIT | PATENT OWNER |
NOTICE of Stipulation to Change Due Dates 1 and 2 | Oct 6, 2016 | PAPER | PATENT OWNER |
Trial Instituted Document | Aug 2, 2016 | PAPER | BOARD |
Scheduling Order | Aug 2, 2016 | PAPER | BOARD |
Patent Owner's Exhibit List | May 3, 2016 | PAPER | PATENT OWNER |
Vertex IPR2016-00558 Preliminary Response | May 3, 2016 | PAPER | PATENT OWNER |
VRTX Exhibit 2003 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2004 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2005 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2006 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2007 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2008 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2009 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2010 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2011 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2012 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2013 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2014 | May 3, 2016 | EXHIBIT | PATENT OWNER |
VRTX Exhibit 2015 | May 3, 2016 | EXHIBIT | PATENT OWNER |
Pro Hac Vice Motion-Lisa M. Ferri | Feb 25, 2016 | PAPER | PATENT OWNER |
VRTX Ex. 2001 Declaration of Lisa M. Ferri in Support of PHV Motion | Feb 25, 2016 | EXHIBIT | PATENT OWNER |
VRTX Ex. 2002 Professional Profile of Lisa M. Ferri | Feb 25, 2016 | EXHIBIT | PATENT OWNER |
Power of Attorney | Feb 24, 2016 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Related Matters | Feb 24, 2016 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Notice of Filing Date Accorded to Petition | Feb 11, 2016 | PAPER | BOARD |
Petition with Cert of Service | Feb 3, 2016 | PAPER | PETITIONER |
Power of Attorney | Feb 3, 2016 | PAPER | PETITIONER |
EX 1001 Pat No 6436989 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1002 Fisher Decl | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1003 Fisher CV | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1004 Fisher Docs List | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1005 Painter | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1006 De Clercq | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1007 Noble | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1008 Alberts | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1009 Cohen | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1010 Hoetelmans | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1011 Dorsey | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1012 Koch Weser | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1013 1997 PDR | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1014 Berger | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1015 Vanhove | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1016 Kim | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1017 Stella | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1018 1995 PDR | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1019 Fleisher | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1020 Coleman | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1021 Roy US Pat 6730679 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1022 Grobelny WO95 07269 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1023 Grobelny WO93 18006 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1024 Grobelny | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1025 Varia | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1026 Balkovec | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1027 Bighley | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1028 Tung WO94 05639 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1029 Prosecution History | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1030 Banker | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1031 Roy WO97 35587 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1032 Provisional App 60 013893 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1033 Tung US Pat 5585397 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1034 Press Rel Adult | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1035 Press Rel Ped | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1036 Gilden | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1037 Order Grant IPR Ranbaxy | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1038 Perry | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1039 Saulnier | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1040 Fleisher | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1041 Amidon 1985 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1042 Amidon 1980 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1043 Berge | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1044 Varia | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1045 Ranbaxy Pet IPR201300024 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1046 Order Terminating IPR201300024 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1047 Masquelier | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1048 Furfine | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1049 Hostetler | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1050 Chong | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1051 Kwei | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1052 Lin 1996 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1053 Lin 1997 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1054 Law | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1055 Wood | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1056 Tyssen | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1057 Young | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1058 Tung | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1059 MacManus Abst 598 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1060 MacManus AIDS 2004 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1061 Paredes | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1062 Sorbera | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1063 Tung US Pat 5723490 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1064 Amended Petition IPR201500405 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1065 Institution Dec IPR201500405 | Feb 3, 2016 | EXHIBIT | PETITIONER |
EX 1066 Dec Deny Rehearing IPR201500405 | Feb 3, 2016 | EXHIBIT | PETITIONER |